Molecular diversity

Molecular diversity, of each natural and synthetic materials, provides a valuable source of compounds for identifying and optimizing new drug leads. Through the quickly evolving technology of combinatorial chemistry, it is now currently  to produce libraries of small molecules to screen for novel bioactivities. The ‘ molecular diversity spectrum ’. In qualitative terms, diversity is viewed as a spectrum ranging from a TOS to the synthesis of all possible molecular entities. Traditional combinatorial chemistry, wherever diversity primarily arises from building block variation, and DOS, where skeletal diversity is also incorporated, produce compound collections between these two extremes.

    Related Conference of Molecular diversity

    May 30-31, 2024

    9th Pharmaceutical Chemistry Conference

    Paris, France
    July 25-26, 2024

    34th Annual European Pharma Congress

    Frankfurt, Germany
    September 11-12, 2024

    9th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    September 25-26, 2024

    4th World Congress on Rare Diseases & Orphan Drugs

    Paris, France
    October 31-01, 2024

    37th World Congress on Pharmacology

    Amsterdam, Netherlands
    November 26-27, 2024

    3rd World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland
    November 26-27, 2024

    3rd World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    November 28-29, 2024

    12th International Conference on Clinical Trials

    Vancouver, Canada
    November 28-29, 2024

    39th World Congress on Pharmacology and Therapeutics

    Paris, France
    November 28-29, 2024

    4th International Conference on Pharmaceutical Chemistry

    Bali, Indonesia
    December 05-06, 2024

    17th World Drug Delivery Summit

    Dubai, UAE

    Molecular diversity Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in